tiprankstipranks
Basilea Pharmaceutica (CH:BSLN)
:BSLN
Switzerland Market

Basilea Pharmaceutica (BSLN) Technical Analysis

Compare
7 Followers

Summary of all the Indicators

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Basilea Pharmaceutica’s (BSLN) Moving Averages Convergence Divergence (MACD) indicator is -0.87, suggesting Basilea Pharmaceutica is a Buy.
Basilea Pharmaceutica’s (BSLN) 20-Day exponential moving average is 52.45, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Sell.
Basilea Pharmaceutica’s (BSLN) 50-Day exponential moving average is 53.20, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Sell.

Basilea Pharmaceutica (BSLN) Pivot Points

Mar 27, 2026, 04:15 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
50.03
50.47
50.83
51.27
51.63
52.07
52.43
Fibonacci
50.47
50.77
50.96
51.27
51.57
51.76
52.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Basilea Pharmaceutica (BSLN) Moving Averages

Mar 27, 2026, 04:15 PM
Period
Simple
Exponential
MA5
51.50Buy
51.53Buy
MA10
51.59Buy
51.77Sell
MA20
52.58Sell
52.45Sell
MA50
54.22Sell
53.20Sell
MA100
52.30Sell
52.43Sell
MA200
50.85Buy
50.50Buy
Basilea Pharmaceutica’s (BSLN) 10-Day exponential moving average is 51.77, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Sell.
Basilea Pharmaceutica’s (BSLN) 100-Day exponential moving average is 52.43, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Sell.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52.6 and Basilea Pharmaceutica’s (BSLN) 50-day simple moving average is 54.22, creating a Sell signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52.6 and Basilea Pharmaceutica’s (BSLN) 100-day simple moving average is 52.30, creating a Sell signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52.6 and Basilea Pharmaceutica’s (BSLN) 200-day simple moving average is 50.85, creating a Buy signal.

Basilea Pharmaceutica (BSLN) Technical Indicators

Mar 27, 2026, 04:15 PM
Name
Value
Implied Action
RSI (14)
44.16
Neutral
STOCH (9,6)
49.95
Neutral
STOCHRSI (14)
40.14
Neutral
MACD (12,26)
-0.87
Buy
ADX (14)
18.80
Buy
Williams %R
-55.10
Buy
CCI (14)
-42.93
Neutral
ATR (14)
1.59
-
Ultimate Oscillator
47.91
Neutral
ROC
-1.52
Sell
Basilea Pharmaceutica’s (BSLN) Relative Strength Index (RSI) is 44.16, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Trend Strength Indicator (ADX) is 18.80, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) Commodity Channel Index (CCI) is -42.93, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Price Rate of Change (ROC) is -1.52, creating a Sell signal.

FAQ

Is BSLN a Buy, Hold, or Sell?
Based on BSLN’s technical indicators, BSLN is a Hold.
    What is BSLN’s RSI (14)?
    BSLN’s RSI (14) is 44.16, which suggests BSLN is a Neutral.
      What is BSLN’s MACD?
      BSLN’s MACD is -0.87, which suggests BSLN is a Buy.
        What is BSLN’s 5-day moving average?
        BSLN’s 5-day moving average is 51.50, which suggests BSLN is a Buy.
          What is BSLN’s 20-day moving average?
          BSLN 20-day moving average is 52.58, which suggests BSLN is a Sell.
            What is BSLN’s 50-day moving average?
            BSLN’s 50-day moving average is 54.22, which suggests BSLN is a Sell.
              What is BSLN’s 200-day moving average?
              BSLN’s 200-day moving average is 50.85, which suggests BSLN is a Buy.
                What is BSLN’s Williams % R (14)?
                BSLN’s Williams % R (14) is -55.10, which suggests BSLN is a Buy.
                  What is BSLN’s CCI (14)?
                  BSLN’s CCI (14) is -42.93, which suggests BSLN is a Neutral.
                    What is the share price of Basilea Pharmaceutica?